Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2351
PUT
Hasbro
HAS
$12.7B
| $4.1M | ﹤0.01% |
50,000
| – | – |
2025 Q3
1 quarter
|
|
2352
Kura Oncology
KURA
$936M
| $4.1M | ﹤0.01% |
394,605
+17,726
| +5% | +$186K |
2019 Q1
27 quarters
|
|
2353
CALL
Humana
HUM
$46.7B
| $4.1M | ﹤0.01% |
16,000
-22,500
| -58% | -$5.9M |
2024 Q3
5 quarters
|
|
2354
CALL
Generac Holdings
GNRC
$12.7B
| $4.09M | ﹤0.01% |
30,000
| – | – |
2025 Q3
1 quarter
|
|
2355
Sensata Technologies
ST
$6.34B
| $4.09M | ﹤0.01% |
122,868
-27,959
| -19% | -$894K |
2013 Q4
48 quarters
|
|
2356
CALL
Zoetis
ZTS
$29.1B
| $4.09M | ﹤0.01% |
32,500
| – | – |
2025 Q2
2 quarters
|
|
|
2357
PUT
Zoetis
ZTS
$29.1B
| $4.09M | ﹤0.01% |
32,500
| – | – |
2025 Q2
2 quarters
|
|
2358
Papa John's
PZZA
$629M
| $4.09M | ﹤0.01% |
106,159
+39,277
| +59% | +$1.73M |
2013 Q2
50 quarters
|
|
2359
Standex International
SXI
$3.59B
| $4.08M | ﹤0.01% |
18,763
+1,703
| +10% | +$395K |
2016 Q1
39 quarters
|
|
|
FOUR.PRA
2360
Shift4 Payments Inc 6.00% Series A Preferred Stock
FOUR.PRA
$517M
| $4.08M | ﹤0.01% |
50,947
+33,548
| +193% | +$2.94M |
2025 Q2
2 quarters
|
|
2361
CALL
VF Corp
VFC
$5.55B
| $4.07M | ﹤0.01% |
+225,000
| New | +$3.65M |
2025 Q4
0 quarters
|
|
|
2362
PUT
VF Corp
VFC
$5.55B
| $4.07M | ﹤0.01% |
+225,000
| New | +$3.65M |
2025 Q4
0 quarters
|
|
2363
NewMarket
NEU
$8.56B
| $4.05M | ﹤0.01% |
5,899
-2,854
| -33% | -$2.18M |
2013 Q2
50 quarters
|
|
2364
Perdoceo Education
PRDO
$2.01B
| $4.05M | ﹤0.01% |
138,082
+15,771
| +13% | +$498K |
2022 Q1
15 quarters
|
|
2365
Willdan Group
WLDN
$1.13B
| $4.05M | ﹤0.01% |
39,057
+9,181
| +31% | +$904K |
2017 Q1
35 quarters
|
|
2366
Newmark Group
NMRK
$2.29B
| $4.04M | ﹤0.01% |
233,264
+3,866
| +2% | +$67.7K |
2017 Q4
32 quarters
|
|
2367
iShares MSCI China ETF
MCHI
$5.96B
| $4.04M | ﹤0.01% |
67,218
+45,041
| +203% | +$2.83M |
2015 Q1
43 quarters
|
|
2368
Credit Acceptance
CACC
$5.54B
| $4.02M | ﹤0.01% |
9,062
-1,200
| -12% | -$556K |
2016 Q2
38 quarters
|
|
2369
Park National Corp
PRK
$3.28B
| $4.02M | ﹤0.01% |
26,400
+4,346
| +20% | +$684K |
2016 Q3
37 quarters
|
|
|
BNY
2370
PUT
Bank of New York Mellon
BNY
$97.5B
| $4.02M | ﹤0.01% |
+34,600
| New | +$3.83M |
2025 Q4
0 quarters
|
|
2371
YPF Sociedad Anonima ADS
YPF
$20.1B
| $4.01M | ﹤0.01% |
111,030
-47,433
| -30% | -$1.57M |
2013 Q2
50 quarters
|
|
2372
iShares MSCI Singapore ETF
EWS
$1.43B
| $4.01M | ﹤0.01% |
145,620
-15,900
| -10% | -$447K |
2022 Q1
15 quarters
|
|
2373
Leonardo DRS
DRS
$9.84B
| $4M | ﹤0.01% |
117,343
-10,804
| -8% | -$399K |
2023 Q1
11 quarters
|
|
2374
Banner Corp
BANR
$2.47B
| $3.99M | ﹤0.01% |
63,754
-1,525
| -2% | -$96.3K |
2016 Q1
39 quarters
|
|
2375
OneSpaWorld
OSW
$2.35B
| $3.99M | ﹤0.01% |
192,516
+20,122
| +12% | +$421K |
2019 Q1
27 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.